| Name / ID | Type | Disease | RRID | Causal gene(s) | Mutation | Originating lab |
|---|---|---|---|---|---|---|
| FC35 | Cell Lines | SCA27B | — |
FGF14 | 300/300 GAA | Montreal Neurological Hospital and Institute |
| FC49 | Cell Lines | SCA27B | — |
FGF14 | 16/383 GAA | Montreal Neurological Hospital and Institute |
| FD104 | Cell Lines | AOA1 | — |
APTX | pW279X/pW279X | — |
| FD105 | Cell Lines | AOA1 | — |
APTX | pW279X/pW279X; sibling of FD106 | — |
| FD106 | Cell Lines | AOA1 | — |
APTX | pW279X/pW279X; sibling of FD105 | — |
| FG4003 | Cell Lines | AOA1 | CVCL_ZT69 |
APTX | 689insT/840delT | The Queensland Institute for Medical Research |
| Fmr1 (CGG)98 knock-in mice | Mouse Models | FXTAS | — |
FMR1 | CGG knock-in mouse with 98 CGG | Erasmus University Rotterdam |
| FMR1 conditional KO clone F17 | Cell Lines | FXTAS | — |
FMR1 | hESC conditional FMR1 knockout | Stanford University School of Medicine |
| FMR1 conditional KO clone F33 | Cell Lines | FXTAS | — |
FMR1 | hESC conditional FMR1 knockout | Stanford University School of Medicine |
| FMR1 KO hESC | Cell Lines | FXTAS | — |
FMR1 | CRISPR/Cas9 generated FMR1 KO; from WCMC-37 | National University of Singapore |
| Fmr1 KO mice | Mouse Models | FXTAS | — |
FMR1 | Homozygous Fmr1 knockout | Erasmus University Rotterdam |
| FMRP-P608L mutation mice | Mouse Models | FXTAS | — |
FMR1 | Fmr1 missense mutation c.1823C>T (Pro608Leu) | The Second Affiliated Hospital of Guangzhou Medical University |
| Forebrain-specific Dab1 knockout mice | Mouse Models | SCA37 | — |
DAB1 | Dab1 conditional knock-out | Kobe University |
| Fragile X premutation knock-in mice | Mouse Models | FXTAS | — |
FMR1 | Knock-in of mouse Fmr1 gene with expanded CGG repeat | National Institutes of Health |
| G671R | Cell Lines | SCA28 | — |
AFG3L2 | p.G671R | IRCCS Ospedale San Raffaele |
| Gfa2-CGG99-eGFP mice | Mouse Models | FXTAS | — |
FMR1 | Human expanded CGG99 trinucleotide repeat segment | University of California |
| GM03561 | Cell Lines | SCA7 | CVCL_AX22 |
ATXN7 | 8/62 CAG | Coriell Institute |
| GM06151 | Cell Lines | SCA3 | CVCL_7451 |
ATXN3 | 24/74 | Coriell Institute |
| GM06153 | Cell Lines | SCA3 | CVCL_7452 |
ATXN3 | 23/71 CAG | Coriell Institute |
| GM06927 | Cell Lines | SCA1 | CVCL_T904 |
ATXN1 | 29/52 CAG | Coriell Institute |
| GZHMCi009-A | Cell Lines | SCA3 | CVCL_C0IB |
ATXN3 | 14/74 CAG | Third affiliated Hospital of Guangzhou Medical University |
| GZHMCi010-A | Cell Lines | SCA3 | CVCL_C0IC |
ATXN3 | 14/74 CAG | Third affiliated Hospital of Guangzhou Medical University |
| GZHMCi011-A | Cell Lines | SCA3 | CVCL_D0F5 |
ATXN3 | 14/63 CAG | Third affiliated Hospital of Guangzhou Medical University |
| H196 clone 7 | Cell Lines | SCA2 | CVCL_AB81 |
ATXN2 | 22/36 CAG | University of Copenhagen and Bioneer A/S |
| H196 clone 7 – Gene corrected | Cell Lines | SCA2 | CVCL_DQ63 |
ATXN2 | 22/22 CAG | University of Copenhagen and Bioneer A/S |
| H201P-iPSC | Cell Lines | AOA1 | — |
APTX | c.602A>C (heterozygous); CRISPR/Cas9 modified from control | Southern Medical University |
| H201R-iPSC | Cell Lines | AOA1 | — |
APTX | c.602A>G (heterozygous); CRISPR/Cas9 modified from control | Southern Medical University |
| H241 | Cell Lines | SCA3 | — |
ATXN3 | 23/83 CAG | University of Copenhagen |
| H249 | Cell Lines | SCA3 | — |
ATXN3 | 14/74 CAG | University of Copenhagen |
| H266 clone 10 | Cell Lines | SCA2 | CVCL_AB82 |
ATXN2 | 44/22 CAG | University of Copenhagen and Bioneer A/S |
| H266 clone 10 – Gene corrected | Cell Lines | SCA2 | CVCL_DQ64 |
ATXN2 | 22/22 CAG | University of Copenhagen and Bioneer A/S |
| H271 clone 1 | Cell Lines | SCA2 | CVCL_9U78 |
ATXN2 | 22/44 CAG | University of Copenhagen and Bioneer A/S |
| H271 clone 1 – Gene corrected | Cell Lines | SCA2 | CVCL_DQ65 |
ATXN2 | 22/22 CAG | University of Copenhagen and Bioneer A/S |
| HA25 | Cell Lines | SCA10 | — |
ATXN10 | — | Fred Hutchinson Cancer Research Center |
| HA26 | Cell Lines | SCA10 | — |
ATXN10 | — | Fred Hutchinson Cancer Research Center |
| HA29 | Cell Lines | SCA10 | — |
ATXN10 | — | Fred Hutchinson Cancer Research Center |
| HIHCNi002-A | Cell Lines | SCA3 | CVCL_VL41 |
ATXN3 | 24/73 CAG | Hertie Institute for Clinical Brain Research |
| HL316 | Cell Lines | MSA/OPCA | — |
GGC expansion in NOTCH2NLC | 15/108 GGC | Taipei Veterans General Hospital |
| HL910 (MSA-P) | Cell Lines | MSA/OPCA | — |
GGC expansion in NOTCH2NLC | 20/122 GGC | Taipei Veterans General Hospital |
| HPS0772, -0773, -0774, -0775 | Cell Lines | MSA/OPCA | CVCL_VM79, CVCL_C6DS, CVCL_C6DT, CVCL_C6DU |
? | — | RIKEN Cell Bank |
| HPS0818, -0819, -0820, -0821, -0822, -0823 | Cell Lines | MSA/OPCA | CVCL_UN41 |
? | — | RIKEN Cell Bank |
| HPS2214, -2215, -2216, -2217, -2218, -2219 | Cell Lines | MSA/OPCA | CVCL_UN42, CVCL_A3PY, CVCL_A3PZ, CVCL_A3QA, CVCL_A3QB, CVCL_A3QC |
? | — | RIKEN Cell Bank |
| I-1 | Cell Lines | CANVAS | — |
RFC1 | AAGGGn expansion + C.1267C>T | Massachusetts General Hospital and Harvard Medical School |
| I-2 | Cell Lines | CANVAS | — |
RFC1 | AAGGGn expansion + C.1267C>T | Massachusetts General Hospital and Harvard Medical School |
| IBCHi002-A | Cell Lines | SCA3 | CVCL_XC41 |
ATXN3 | 17/70 CAG | Institute of Bioorganic Chemistry of Polish Academy of Sciences |
| IBMS-iPSC-050-04 | Cell Lines | SCA3 | CVCL_A9WA |
ATXN3 | — | Academia Sinica |
| IBMS-iPSC-050-05 | Cell Lines | SCA3 | CVCL_A9WB |
ATXN3 | — | Academia Sinica |
| IBMS-iPSC-051-02 | Cell Lines | SCA2 | CVCL_A9WC |
ATXN2 | — | Academia Sinica |
| IBMS-iPSC-051-05 | Cell Lines | SCA2 | CVCL_A9WD |
ATXN2 | — | Academia Sinica |
| IBMS-iPSC-052-01 | Cell Lines | SCA2 | CVCL_A9WE |
ATXN2 | — | Academia Sinica |
Twenty Twenty-Five
Designed with WordPress